Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02863601 · ClinicalTrials.gov registry record
Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 25
- Enrollment target
NCT02863601 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 25 participants.
The verdict
NCT02863601 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine whether buprenorphine and metabolite exposure (reflected as the dose-adjusted plasma concentration x time curve \[AUC\]) differs during pregnancy and between pregnancy and the postpartum state.The study will define the pharmacokinetics of buprenorphine and determine if there is a better way to gauge dosing based on objective, physiological parameters of satiety. The study will define neonatal exposure to buprenorphine through breast milk.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-08 |
| Est. Completion | 2022-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02863601
The ClinicalTrials.gov registry entry for NCT02863601 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02863601 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02863601 about?
NCT02863601 is a clinical study titled "Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics". The primary purpose of this study is to determine whether buprenorphine and metabolite exposure (reflected as the dose-adjusted plasma concentration x time curve \[AUC\]) differs during pregnancy and between pregnancy and the postpartum state.The study will define the pharmacokinetics of buprenorphi...
What is the current status of trial NCT02863601?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2016-08. Estimated completion is 2022-05.
Who is sponsoring clinical trial NCT02863601?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.